[A10-03] Aromatase inhibitors in female breast cancer

Last updated 15.11.2016

Project no.:
A10-03

Commission:
Commission awarded on 19.07.2010 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Cancer

15.11.2016

Aromatase inhibitors for breast cancer: advantages over tamoxifen in early-stage disease

Longer survival, later recurrences / Evidence for late-stage disease much poorer

Current document

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.